Camber Capital Management LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
31
Total Value
2751627620
Accession Number
0001654954-25-005756
Form Type
13F-HR
Manager Name
Camber Capital Management LP
Data Enrichment
94% identified
29 identified2 unidentified

Holdings

31 positions
Manager:
Search and click to pin securities to the top
Page 2 of 2
MYRIAD GENETICS INC
Shares:
2350000(-24.2%)
Value:
$20.8B(+48944.7%)
ZimVie Inc.
Shares:
1885000(-30.8%)
Value:
$20.4B(+53453.9%)
MoonLake Immunotherapeutics
Shares:
441000(+0.0%)
Value:
$17.2B(+72051.9%)
Denali Therapeutics Inc.
Shares:
1250000(-44.4%)
Value:
$17.0B(+36959.8%)
ANAPTYSBIO, INC
Shares:
750000(-40.0%)
Value:
$13.9B(+84144.7%)
Theravance Biopharma, Inc.
Shares:
1000000(+0.0%)
Value:
$8.9B(+94799.0%)
10x Genomics, Inc.
Shares:
1000000(+0.0%)
Value:
$8.7B(+60693.9%)
Inogen Inc
Shares:
975000(-51.3%)
Value:
$7.0B(+37804.8%)
Structure Therapeutics Inc.
Shares:
300000(+0.0%)
Value:
$5.2B(+63727.4%)
ORASURE TECHNOLOGIES INC
Shares:
900000(-78.8%)
Value:
$3.0B(+19668.0%)
GENMAB A/S
Shares:
50000(+0.0%)
Value:
$979.0M(+93673.9%)